Clinical and Lab Diagnostics - What Factors Affect Antibody Production?
Can't see this email? View it online
   
  Clinical and Lab Diagnostics  
  The latest clinical and lab diagnostics news from News Medical  
 Are Serological Tests Unreliable? Or the Protein Reagents?Are Serological Tests Unreliable? Or the Protein Reagents?
 
Serological tests are widely used in diagnostics, and are produced rapidly to test for new disease, such as COVID-19, but these rely on protein reagent quality.
 
   What Factors Affect Antibody Production?What Factors Affect Antibody Production?
 
To reduce the spread and severity of COVID-19, many researchers around the world have investigated whether the antibodies have long-term protective effects.
 
   Multisystem Inflammatory Syndrome in Children (MIS-C)Multisystem Inflammatory Syndrome in Children (MIS-C)
 
MIS-C is a rare multisystem inflammatory condition that affects children & adolescents. It is associated with exposure to COVID-19.
 
 A highly sensitive and specific antibody test for COVID-19
 
A highly sensitive and specific antibody test for COVID-19A new proof-of-concept study by UK researchers, currently available on the medRxiv* preprint server, describes the development of an enzyme-linked immunosorbent assay that can be used when lower levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific-antibodies are present in serum and saliva samples.
 
 
 Benefits of PSA screening for prostate cancer may outweigh potential harms
 
Benefits of PSA screening for prostate cancer may outweigh potential harmsThe benefits of the prostate-specific antigen (PSA) test to screen men for prostate cancer may be greater than the harm, according to a study published today in the New England Journal of Medicine.
 
 
 Simple blood test found to accurately diagnose and classify brain tumors
 
Simple blood test found to accurately diagnose and classify brain tumorsA simple but highly sensitive blood test has been found to accurately diagnose and classify different types of brain tumors, resulting in more accurate diagnosis, less invasive methods and better treatment planning for patients, in the future.
 
 
 Pixatimod is active in lab studies against SARS-CoV-2
 
Pixatimod is active in lab studies against SARS-CoV-2The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) circulating the world has caused over 9.6 million cases and over 490,000 deaths as of June 26, 2020. With neither an effective vaccine nor therapeutic drug yet available, intensive and widespread research is ongoing to develop a pharmacological intervention that will halt the global pandemic.
 
 
 Antibody tests may give false hope of immunity, health experts warn
 
Antibody tests may give false hope of immunity, health experts warnAmid the coronavirus pandemic, health experts warn against the use of antibody tests to determine if a person has immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An antibody test determines if a person developed antibodies against the infection due to past exposure.
 
 
 New rapid genomic testing can improve therapy selection for colorectal cancer patients
 
New rapid genomic testing can improve therapy selection for colorectal cancer patientsGenomic mutation testing is critical to therapeutic selection and management of patients with colorectal cancer. In a new multicenter study, researchers compared a new cartridge-based laboratory testing device called the Idylla automated system (Biocartis) to current standard-of-care testing methods.
 
 
 USA riddled with SARS-CoV-2 - 80% undetected
 
USA riddled with SARS-CoV-2 - 80% undetectedThe coronavirus pandemic is actively spreading across the globe, affecting 188 countries and territories. The United States remains the country with the highest number of infections. The official tally reveals that the U.S. has more than 2.347 million people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).